{"slideshow_credits": null, "snippet": "The study was among many being presented at the annual meeting of the American Society of Clinical Oncology.", "abstract": "Study presented at annual meeting of American Society of Clinical Oncology reports that women with ovarian cancer may be able to stave off relapses for extra half-year or so by taking GlaxoSmithKline drug Votrient, already approved to treat kidney cancer.", "section_name": "Health", "print_page": "18", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/02/health/kidney-drug-found-to-hold-off-relapses-of-ovarian-cancer.html", "lead_paragraph": "The study was among many being presented at the annual meeting of the American Society of Clinical Oncology.", "headline": {"main": "Drug Used to Treat Kidney Cancer May Hold Off Relapses of Ovarian Cancer", "print_headline": "Drug Used to Treat Kidney Cancer May Hold Off Relapses of Ovarian Cancer"}, "_id": "51aa084340e9ec65d203ab07", "word_count": "856", "multimedia": [], "pub_date": "2013-06-02T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Kidneys", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Ovarian Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "American Society of Clinical Oncology", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}